Dr. Hamed Hajipour | Medicine and Dentistry |Best Researcher Award  🏆

Doctor. Hamed Hajipour, Tabriz university of medical science 🎓

Professional Profile 

🧑‍🎓📚 Early Academic Pursuits

Hamed Hajipour embarked on his academic journey at the University of Tabriz, where he earned his B.S. degree in Biology in 2011. His strong foundational skills and academic diligence led him to pursue higher education in the field of Clinical Biochemistry at the Faculty of Medical Sciences, Tabriz University of Medical Sciences. During his master’s studies from 2012 to 2015, Hamed focused on the cytotoxic effects of free ellagic acid and loaded solid lipid nanoparticles (SLN) on the prostate cancer cell line (PC3). His research, under the guidance of Dr. Akbar Hasani and Dr. Hamed Hamishehkar, achieved a Grade Point Average (GPA) of 18.34, showcasing his dedication and proficiency in his field. In 2016, Hamed advanced his studies further by enrolling in a PhD program in Reproductive Biology at the Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, where he graduated in 2021 with a GPA of 18.63.

🧪 Professional Endeavors

Hamed’s professional journey is marked by his extensive research and contributions to the field of reproductive biology and clinical biochemistry. His PhD thesis, titled “Investigation of the effect of human chorionic gonadotropin (hCG)-enriched uterine fluid-derived exosomes on the expression of endometrial-receptivity-associated genes in vitro,” was supervised by Prof. Mohammad Nouri and Prof. Laaya Farzadi. Throughout his academic and professional career, Hamed has actively engaged in research projects, demonstrating a keen interest in nanotechnology applications in medicine, specifically in drug delivery systems and their effects on cancer cells and endometrial receptivity.

🔬 Contributions and Research Focus

Hamed Hajipour has made significant contributions to reproductive biology and nanomedicine. His research focuses on the enhancement of endometrial receptivity, drug resistance in cancer treatment, and the development of nanostructured lipid carriers (NLCs) for targeted drug delivery. He has authored numerous publications in prestigious journals, including Naunyn-Schmiedeberg’s Archives of Pharmacology, Life Sciences, and Systems Biology in Reproductive Medicine. His notable works include studies on sildenafil citrate-loaded NLCs, galangin-loaded NLCs, and the cytotoxic effects of various compounds on cancer cell lines. Hamed’s innovative research has contributed to understanding the potential of nanotechnology in improving cancer treatment outcomes and reproductive health.

🏆 Accolades and Recognition

Hamed’s dedication to his field has earned him recognition within the scientific community. He has presented his research at national and international conferences, including the 23rd Congress on Reproductive Biomedicine in Tehran, Iran, and the 34th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) in Barcelona, Spain. Hamed is also an active member of the Iranian Society for Embryology and Reproductive Biology, where he continues to collaborate with other professionals in his field.

🌟 Impact and Influence

Hamed Hajipour’s research has significantly impacted the fields of reproductive biology and nanomedicine. His work on the development of targeted drug delivery systems has the potential to improve the efficacy of cancer treatments and enhance endometrial receptivity in assisted reproductive technologies. By exploring the mechanisms of drug resistance and the role of exosomes in reproductive health, Hamed’s research contributes to a better understanding of the complex interactions between nanomaterials and biological systems.

🚀 Legacy and Future Contributions

As Hamed continues to explore new frontiers in reproductive biology and nanomedicine, his work promises to influence the future of personalized medicine and reproductive health. His commitment to innovation and collaboration positions him as a leading figure in his field, with the potential to make lasting contributions to science and medicine. Through his research and mentorship, Hamed Hajipour aims to inspire the next generation of scientists and researchers to pursue excellence in their respective fields.

📖Publications : 

Paper Title: Protective effects of canthaxanthin-loaded seminal exosomes on the quality of human spermatozoa during cryopreservation”

Authors: Hassoon Ali, K., Ibrahim Yahiya, Y., Almajidi, Y.Q., Ghorbani, M., Mortazavi Moghadam, F.
Journal: Journal of Drug Delivery Science and Technology
Volume: 96
Issue: N/A
Pages: 105696
Year: 2024

Paper Title:  “Engineered exosome as a biological nanoplatform for drug delivery of Rosmarinic acid to improve implantation in mice with induced endometritis”

Authors: Taravat, M., Asadpour, R., Jafari Jozani, R., Khordadmehr, M., Hajipour, H.
Journal: Systems Biology in Reproductive Medicine
Volume: 70
Issue: 1
Pages: 3–19
Year: 2024

Paper Title:  “Soy Protein Isolate/Sodium Alginate Hybrid Hydrogel Embedded with Hydroxyapatite for Tissue Engineering”

Authors: Alesaeidi, S., Kahrizi, M.S., Ghorbani Tajani, A., Hajipour, H., Ghorbani, M.
Journal: Journal of Polymers and the Environment
Volume: 31
Issue: 1
Pages: 396–405
Year: 2023

Paper Title:  “Targeted nanostructured lipid carrier containing galangin as a promising adjuvant for improving cytotoxic effects of chemotherapeutic agents”

Authors: Hajipour, H., Nouri, M., Ghorbani, M., Emameh, R.Z., Taheri, R.A.
Journal: Naunyn-Schmiedeberg’s Archives of Pharmacology
Volume: 394
Issue: 12
Pages: 2353–2362
Year: 2021

Paper Title:  “Sildenafil citrate–loaded targeted nanostructured lipid carrier enhances receptivity potential of endometrial cells via LIF and VEGF upregulation”

Authors: Hajipour, H., Sambrani, R., Ghorbani, M., Mirzamohammadi, Z., Nouri, M.
Journal: Naunyn-Schmiedeberg’s Archives of Pharmacology
Volume: 394
Issue: 11
Pages: 2323–2331
Year: 2021

Paper Title:  “A human chorionic gonadotropin (hCG) delivery platform using engineered uterine exosomes to improve endometrial receptivity”

Authors: Hajipour, H., Farzadi, L., Roshangar, L., Fattahi, A., Nouri, M.
Journal: Life Sciences
Volume: 275
Issue: N/A
Pages: 119351
Year: 2021

Paper Title: “Cell-based endometrial regeneration: current status and future perspectives”

Authors: Keyhanvar, N., Zarghami, N., Bleisinger, N., Nouri, M., Dittrich, R.
Journal: Cell and Tissue Research
Volume: 384
Issue: 2
Pages: 241–254
Year: 2021

Paper Title:  “Cytokines in embryonic secretome as potential markers for embryo selection”

Authors: Bahrami-Asl, Z., Hajipour, H., Rastgar Rezaei, Y., Nouri, M., Dominguez, F.
Journal: American Journal of Reproductive Immunology
Volume: 85
Issue: 5
Pages: e13385
Year: 2021

Paper Title:  “An update on platelet-rich plasma (PRP) therapy in endometrium and ovary related infertilities: clinical and molecular aspects”

Authors: Hajipour, H., Farzadi, L., Latifi, Z., Nouri, M., Dittrich, R.
Journal: Systems Biology in Reproductive Medicine
Volume: 67
Issue: 3
Pages: 177–188
Year: 2021

Paper Title: “Sensitization of MDA-MBA231 breast cancer cell to docetaxel by myricetin loaded into biocompatible lipid nanoparticles via sub-G1 cell cycle arrest mechanism”

Authors: Maroufi, N.F., Vahedian, V., Mazrakhondi, S.A.M., Ghanbarzadeh, S., Sabzichi, M.
Journal: Naunyn-Schmiedeberg’s Archives of Pharmacology
Volume: 393
Issue: 1
Pages: 1–11
Year: 2020

Dr. Hamed Hajipour | Medicine and Dentistry |Best Researcher Award- 1680

You May Also Like